Lead Plaintiff Appointed in Cassava Sciences Class Action — Here’s How You Can Recover Your Losses

Court: W.D. Texas

Case: 1:24-CV-1525

Lead Plaintiff has been appointed to represent investors in the class action against Cassava Sciences.

What is this lawsuit about?

On November 25, 2024, Cassava announced that Simufilam failed to achieve any goals in its Phase 3 trial.

Following this, SAVA plummeted by 83.76%.

Then, on December 12, 2024, shareholders filed a claim against Cassava Sciences.

What can you do to recover your losses now?

We’re keeping track of all updates and will notify SAVA investors about potential recovery.

More than 600 companies are currently facing securities class action lawsuits, and over 100 are already paying settlements. Connect your brokerage account to automatically check which ones you may have missed.